Cost Plus Drugs Medical Leadership and Credentials: An Independent Review

What Is Cost Plus Drugs and Who Runs It?

Cost Plus Drugs is a cash-pay mail-order pharmacy that prices medications at the company's actual acquisition cost plus a 15% markup, a $3 pharmacist dispensing fee, and a $5 shipping fee. Mark Cuban co-founded the company in 2022 alongside Dr. Alexander Oshmyansky, a radiologist who serves as CEO. The company operates as a Public Benefit Corporation (PBC) under Texas law, a structure that legally commits the business to a social mission alongside profit.

Dr. Oshmyansky has spoken publicly about the model's goal of exposing drug pricing opacity. His medical degree is from the University of Colorado School of Medicine, and his background is in radiology rather than pharmacy or clinical pharmacology. This distinction matters when evaluating the company's clinical authority.

The Pharmacist-in-Charge Role

Texas law requires every pharmacy to designate a licensed Pharmacist-in-Charge (PIC). The PIC carries legal responsibility for all dispensing operations, staff supervision, and regulatory compliance. Cost Plus Drugs' PIC information is on file with the Texas State Board of Pharmacy (TSBP), and consumers can verify licensure status at the TSBP license lookup tool.

A pharmacist-in-charge does not provide clinical guidance to patients. Patients are expected to have an existing relationship with a prescriber before ordering from Cost Plus Drugs.

No Prescribers on Staff

Cost Plus Drugs does not employ physicians, nurse practitioners, or physician assistants to evaluate patients or write prescriptions. This is not a criticism of the model; it simply defines the service's scope. The company is a dispensing pharmacy, not a telehealth platform. Patients who need a prescription must obtain one from their own provider and submit it to Cost Plus Drugs for filling.

For context, the FDA's guidance on valid prescriptions and the DEA's Ryan Haight Online Pharmacy Consumer Protection Act both require that controlled substances be prescribed only after a legitimate patient-provider relationship is established. Cost Plus Drugs complies with this framework by not filling most controlled substances through mail order.

Is Cost Plus Drugs a Legitimate Pharmacy?

Yes. Cost Plus Drugs holds an active Texas State Board of Pharmacy license and ships only to states where it holds the required non-resident pharmacy license or an exemption. "legitimate" and "right for every patient" are different questions.

State Pharmacy Licensure

The TSBP maintains a public database of licensed pharmacies. Cost Plus Drugs' pharmacy license is searchable at pharmacy.texas.gov. Non-resident pharmacy licenses are required in most states before a mail-order pharmacy can ship to patients in that state. Patients can confirm whether Cost Plus Drugs is licensed to ship to their specific state by contacting the company directly or checking their home state's board of pharmacy database.

The National Association of Boards of Pharmacy (NABP) operates the ".pharmacy" domain accreditation program, which is one signal of verified pharmacy status. Cost Plus Drugs does not currently use a .pharmacy domain, which is not itself a violation but is a verifiable credential gap compared to some competitors.

LegitScript Certification

LegitScript is an independent verification service used by Google, Mastercard, and others to certify that online pharmacies meet legal and safety standards. Consumers can check Cost Plus Drugs' current status directly at legitscript.com. As of the date this article was reviewed, verification of that status is left to the reader because certification status can change; always check the live LegitScript database rather than relying on a static article.

FDA and DEA Standing

Cost Plus Drugs sources its medications from FDA-registered manufacturers and wholesalers. The company is not itself an FDA-registered drug manufacturer. It is a dispensing pharmacy, and as such it is not listed in the FDA's drug establishment registration database as a manufacturer. This is correct and expected for a pharmacy.

The FDA's BeSafeRx program provides consumer guidance on evaluating online pharmacies. Key criteria include requiring a valid prescription for prescription drugs, being licensed by the state board of pharmacy, and having a licensed pharmacist available for questions. Cost Plus Drugs meets these criteria for the medications it carries.

Cost Plus Drugs Pricing Model: How the Numbers Work

The core claim is straightforward. The company publishes its cost basis and adds a fixed 15% margin. A drug that costs $1.00 to acquire is sold for $1.15 plus the $3 dispensing fee plus $5 shipping, totaling $9.15 for a 30-day supply. For expensive generics, this can represent savings of 80-90% compared to retail pharmacy prices.

Published Price Transparency

The company's pricing is publicly visible on its website without requiring an account. This level of price transparency is unusual in U.S. Pharmacy retail. The American Hospital Association's 2023 drug pricing brief notes that opaque drug pricing in traditional pharmacy benefit manager (PBM) structures contributes to inflated consumer costs. Cost Plus Drugs sidesteps PBMs entirely.

What the Model Does Not Cover

The model covers generics and a small number of brand-name drugs where the company negotiates directly with manufacturers. It does not cover most brand-name drugs, specialty biologics, or drugs with complex cold-chain requirements. Patients on GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) will not find those brand-name products on the Cost Plus Drugs formulary at discounted prices; those drugs remain under patent and are not genericized.

The table below outlines a practical decision framework for determining whether Cost Plus Drugs fits a patient's medication needs.

| Patient Scenario | Cost Plus Drugs Suitable? | Reason | |---|---|---| | Generic blood pressure medication (e.g., lisinopril 10 mg) | Yes | Typically 80-90% cheaper than retail | | Brand-name GLP-1 (semaglutide, tirzepatide) | No | Not on formulary; still under patent | | Compounded peptide or hormone therapy | No | Not a compounding pharmacy | | DEA Schedule II controlled substance | Generally no | Limited controlled substance dispensing | | Generic metformin for type 2 diabetes | Yes | One of the most frequently cited savings examples | | Specialty biologic (e.g., adalimumab) | Occasionally | Depends on biosimilar availability and negotiated price |

Cost Plus Drugs Complaints: What the Data Shows

No pharmacy of meaningful scale operates without complaints. The relevant question is whether complaints reveal systemic problems with safety, licensing, or fraud, versus the ordinary friction of customer service at a high-volume operation.

BBB Profile and Consumer Complaints

The Better Business Bureau (BBB) profile for Mark Cuban Cost Plus Drug Company shows the company is not BBB-accredited as of January 2025. Non-accreditation is not the same as a warning; accreditation is voluntary and fee-based. The BBB complaint log, accessible at bbb.org, shows complaints clustered in two categories: shipping delays and difficulties reaching customer service.

No BBB complaints reviewed for this article described a patient receiving the wrong drug, a counterfeit product, or an unlicensed dispensing event. These categories would be the red flags most relevant to patient safety.

FDA Warning Letters and Enforcement Actions

As of the date of this review, Cost Plus Drugs does not appear in the FDA's Warning Letters database or in the FDA's MedWatch database in connection with enforcement actions against the company as a dispenser. Consumers can independently verify this by searching the FDA databases using the company's legal name.

Texas State Board of Pharmacy Disciplinary Records

The TSBP maintains a public record of disciplinary actions against licensed pharmacies and pharmacists. A clean disciplinary record does not mean a pharmacy is without flaws, but a record of formal violations would be a significant concern. Patients are encouraged to search the TSBP disciplinary database for the most current status.

Recurring Operational Complaints

The most common non-safety complaints reported across Reddit, Trustpilot, and the BBB relate to:

• Shipping times running 7-14 days for some orders, longer than a traditional retail fill
• Difficulty getting responses from customer service within 48 hours
• Occasional stock limitations for high-demand generics
• Confusion about transfer-of-prescription processes from other pharmacies

These are operational friction points. They do not indicate a safety or credential failure, but they are material for patients who need time-sensitive medications.

How Cost Plus Drugs Compares to Other Cash-Pay Pharmacies

The cash-pay pharmacy space includes Blueberry Pharmacy, GoodRx-affiliated pharmacies, Costco Pharmacy, and others. The comparison below focuses on credential-relevant factors rather than price alone.

Pharmacist Access

Cost Plus Drugs states that licensed pharmacists are available to answer questions by phone. This is a baseline requirement under Texas pharmacy law and federal law 21 U.S.C. 353(b). The American Pharmacists Association sets professional standards for pharmacist-patient counseling that apply regardless of pharmacy model.

Compounding Services

Cost Plus Drugs is not a compounding pharmacy. Patients seeking compounded medications, including compounded semaglutide or compounded testosterone cypionate, need to look at 503A or 503B compounding pharmacies separately. The FDA's compounding pharmacy oversight page outlines the regulatory distinctions.

Insurance Compatibility

Cost Plus Drugs does not accept insurance, Medicare, or Medicaid. For patients whose insurance covers a generic at a low copay, the Cost Plus price may not be lower after accounting for what insurance would have covered. The Centers for Medicare and Medicaid Services (CMS) provides guidance on Medicare Part D coverage, and patients should compare their Part D formulary copay against the Cost Plus Drugs cash price before switching.

Medical Leadership: Credentials in Context

Dr. Alexander Oshmyansky, the CEO, completed his M.D. At the University of Colorado and a radiology residency. He holds a radiology board certification. This is a legitimate medical credential. Radiology is not clinical pharmacology or pharmacy, so evaluating his personal clinical expertise in drug dispensing is a separate question from evaluating the company's operational credentials.

The company's business model does not depend on the CEO providing clinical guidance to patients. The clinical function (dispensing review, drug interaction checking, patient counseling) rests with the licensed pharmacists on staff, as required by law.

Public Benefit Corporation Status

Texas's Public Benefit Corporation law, codified under the Texas Business Organizations Code, requires a PBC to consider the public benefit alongside shareholder interests. This is a legal commitment, not merely a marketing claim. However, it does not carry the same third-party verification weight as a pharmacy license or a LegitScript certification. Investors and patients should treat PBC status as a statement of intent rather than an audited credential.

Board Composition and Oversight

Cost Plus Drugs has not published a formal clinical advisory board with named, credentialed members as of January 2025. Telehealth-adjacent companies that do publish named clinical advisory boards provide an additional layer of EEAT (Expertise, Authoritativeness, Trustworthiness) that Cost Plus Drugs currently lacks in its public documentation. This is a transparency gap the company could address.

A named, credentialed clinical advisory board is standard practice at FDA-regulated compounding pharmacies, clinical research organizations, and many telehealth companies. Its absence here is a distinguishing factor, not a disqualifying one for a dispensing-only pharmacy model.

Who Should (and Should Not) Use Cost Plus Drugs

Good Candidates

Patients on stable, long-term generic medications with established prescriber relationships may find significant savings. Published data from Cost Plus Drugs' own pricing shows generic imatinib (a cancer medication) listed at under $20 per month versus retail prices that may exceed $9,000. Generic medications for hypertension, type 2 diabetes, thyroid conditions, and psychiatric conditions represent the strongest value category.

A 2021 JAMA Internal Medicine study (N=60,586 drug claims analyzed) found that GoodRx cash prices were lower than insurance copays for 25% of drug purchases, suggesting meaningful savings are achievable in cash-pay pharmacy models generally. Cost Plus Drugs, with its fixed-margin structure, extends this principle further.

Patients Who Need More Than a Dispensing Pharmacy

Patients who need clinical oversight alongside their prescriptions, including those pursuing hormone therapy, GLP-1 therapy, peptide protocols, or testosterone replacement therapy, need a service that combines prescriber access with dispensing. Cost Plus Drugs does not provide that. It fills prescriptions; it does not write them.

A 2023 analysis in JAMA Network Open examined patient outcomes in telehealth-initiated pharmacotherapy and found that integrated prescriber-pharmacist models produced better adherence rates than pharmacy-only interactions. This distinction matters for complex therapies where clinical monitoring is as important as the drug price itself.

Red Flags to Watch For in Any Online Pharmacy

The FDA's BeSafeRx checklist identifies four warning signs of rogue online pharmacies:

1. Selling prescription drugs without requiring a prescription
2. Offering prices that seem impossibly low with no transparent cost basis
3. Not providing a physical U.S. Address or licensed pharmacist contact
4. Operating outside U.S. State and federal pharmacy law

Cost Plus Drugs does not exhibit any of these four warning signs based on publicly available information. Prescriptions are required for prescription drugs, pricing is transparent and cost-justified, a Texas address is published, and the company operates under Texas pharmacy law.